Company News: Pfizer (PFE) quarterly earnings beat analysts’ forecast

Market news

30 October 2018

Company News: Pfizer (PFE) quarterly earnings beat analysts’ forecast

Pfizer (PFE) reported Q3 FY 2018 earnings of $0.78 per share (versus $0.67 in Q3 FY 2017), beating analysts' consensus estimate of $0.75.

The company's quarterly revenues amounted to $13.298 bln (+1.0% y/y), missing analysts' consensus estimate of $13.533 bln.

The company also narrowed FY 2018 EPS guidance to $2.98-3.02 from $2.95-3.05 (versus analysts' consensus estimate of $2.99) and lowered revenues guidance to $53-53.7 bln from $53.5-55.5 bln (versus analysts' consensus estimate of $54.16 bln.

PFE fell to $41.70 (-3.54%) in pre-market trading.

Company News: MasterCard (MA) quarterly results beat analysts’ estimates

Company News: General Electric (GE) quarterly results beat analysts’ expectations

Market Focus

Material posted here is solely for information purposes and reliance on this may lead to losses. Past performances are not a reliable indicator of future results. Please read our full disclaimer

Open Demo Account & Personal Page

Personal area

support@teletradepartners.com

Risk Warning: Trading in the financial markets (including trading on margin) provides a wide range of opportunities and enables investors ready to take risks to make high profits, but it carries a potentially high level of risk of loss. Therefore, prior to trading you should take into careful consideration whether such operations are suitable for you in terms of your level of knowledge and financial situation.